no jab, no joy

Covid-19 vaccines in Africa: Mo Ibrahim and others lament sorry state of access

By Xolisa Phillip, in Johannesburg

Posted on January 25, 2021 17:18

Egypt starts coronavirus disease (COVID-19) vaccination © Doctor Abdel Menoim Selim and nurse Ahmed Hamdan Zayed, the first two Egyptians to receive Chinese Sinopharm COVID-19 vaccine, arrive to a news conference inside a tent set up outside the Abou Khalifa hospital in Ismailia, Egypt 24 January 2021. REUTERS/Shokry Hussien
Doctor Abdel Menoim Selim and nurse Ahmed Hamdan Zayed, the first two Egyptians to receive Chinese Sinopharm COVID-19 vaccine, arrive to a news conference inside a tent set up outside the Abou Khalifa hospital in Ismailia, Egypt 24 January 2021. REUTERS/Shokry Hussien

Sudanese billionaire businessman and philanthropist Mo Ibrahim voiced “shock and sadness” at the spectacle of the Global South being excluded from the mass Covid-19 vaccination drive taking place in richer countries.

Ibrahim expressed this view while delivering the keynote address on Wednesday 20 January during Deloitte Africa’s Outlook Conference, which took place virtually. The disparities in vaccine access and distribution were a central theme during the conference.

Hippolyte Fofack, the chief economist at Afreximbank, and Martyn Davies, the managing director of emerging markets and Africa at Deloitte Africa, both sounded the alarm about the economic consequences of the region’s delayed access to Covid-19 vaccines.

READ MORE Vaccine won’t work against South Africa coronavirus variant, worry UK scientists

Since April 2020, Afreximbank has been working with the African Union (AU) to secure supply for the region. In addition, the trade-finance institution has approached European Union (EU) and Organisation of Economic Development and Co-operation (OECD) states, such as Canada, to procure supplies for Africa.

Shocking and sad state of affairs

“I am concerned about the situation of the vaccine. I think all of us listened to the director-general of the World Health Organisation two days ago. [There were] shocking numbers, 39 million doses of vaccine were administered in … 49 rich countries,” said Ibrahim.

“Over 40 million doses by now. And the rest of the countries – 150 countries or so – only 25. It’s not 25 million, not 25 thousand, not 25 hundred. It’s just 25. I think it’s really shocking. It’s very sad,” he added.

Ibrahim also pointed out: “A country like Canada has procured five doses of the vaccine for every citizen. Why? I don’t know. What are they going to do with the extra three? We’ll see. This is a problem because the pandemic is a global issue.”

Ibrahim also asked what if there are delays in delivering vaccines to Africa, as well as to other low- and middle-income countries, where most of the world’s population lives.

Wasted efforts?

The telecoms investor argued that the current situation might render the vaccine drives in the Global North futile in the absence of similar efforts in the Global South. Ibrahim cited recently discovered mutations in Brazil and South Africa, and wondered if the lack of adequate vaccination drives in the Global South would lead to more such mutations.

If that were to happen, it would undermine current vaccine efforts.

The economic repercussions of 2020 make the task of securing adequate vaccine supplies for Africa urgent. South Africa was the worst-affected by capital outflows during the pandemic, having recorded $1.8bn in capital flight last year, according to Fofack.

Africa needs shot in the arm

“The best way to unlock African economies is having access to the vaccine,” said the Afreximbank chief economist.

“We’ve been working with the … [AU] to adopt a continental approach to access to vaccines in a way that will ensure Africa is not left behind,” said Fofack. “We’ve been mobilising support to have direct access.”

READ MORE Why COVID-19 vaccines pose ‘equity and social justice concerns’

“Through our pandemic financing, we are also exploring the options – since supply is a major constraint – of manufacturing some of the generics of those vaccines within the continent. I think South Africa has the capacity to do that in terms of manufacturing. That is a second option,” added Fofack.

Free-trade hope

Deloitte Africa’s Outlook Conference also discussed other ways that African economies can grow.  Afreximbank also sees the region’s growth potential in the geographical diversification of its trade through the African Continental Free Trade Area (AfCFTA) agreement.

For that to happen, the AfCFTA agreement would have to be followed through with the strict implementation of rules of origin.

READ MORE AfCFTA is key to post-COVID recovery – Islamic Trade Finance

The agreement could help the continent draw on economies of scale to improve competitiveness and productivity.

Doing so might shift foreign direct investment towards manufacturing and industry, which could insulate Africa from shocks.

Bottom line

“Without mass vaccinations, we risk economic marginalisation,” warned Davies. “The great hope is vaccination. This would provide certainty,” Davies concluded.

Understand Africa's tomorrow... today

We believe that Africa is poorly represented, and badly under-estimated. Beyond the vast opportunity manifest in African markets, we highlight people who make a difference; leaders turning the tide, youth driving change, and an indefatigable business community. That is what we believe will change the continent, and that is what we report on. With hard-hitting investigations, innovative analysis and deep dives into countries and sectors, The Africa Report delivers the insight you need.